Journal of Digestive Cancer Research

  • 제12권2호
  • /
  • Pages.82-89
  • /
  • 2024
  • /
  • 2950-9394(pISSN)
  • /
  • 2950-9505(eISSN)
대한소화기암연구학회 (Korean Society of Gastrointestinal Cancer Research)
권호 표지
DOI QR코드

DOI QR Code

대장암과 비만

Colorectal Cancer and Obesity

  • 조형호 (대구가톨릭대학교 의과대학 내과학교실)
  • Hyeong Ho Jo (Department of Internal Medicine, Daegu Catholic University School of Medicine)
  • 투고 : 2024.04.22
  • 심사 : 2024.06.02
  • 발행 : 2024.08.20
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

The increasing prevalence of obesity globally underscores its pivotal role in the development of colorectal cancer (CRC). Epidemiological evidence consistently correlates obesity with CRC, implicating intricate pathways such as insulin resistance, chronic inflammation, and hormonal dysregulation. Understanding the impact of obesity on CRC recurrence, therapeutic efficacy, and overall survival is paramount. Lifestyle modifications, including weight reduction, offer promising avenues for mitigating CRC risk. Recognizing obesity as a modifiable risk factor highlights its importance in shaping CRC prevention and therapeutic paradigms.

키워드

과제정보

This work was supported by research grants from Daegu Catholic University in 2022.

참고문헌

  1. Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2024;74:229-263. https://doi.org/10.3322/caac.21834
  2. Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin 2023;73:17-48. https://doi.org/10.3322/caac.21763
  3. Kang MJ, Jung KW, Bang SH, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2020. Cancer Res Treat 2023;55:385-399. https://doi.org/10.4143/crt.2023.447
  4. Jasperson KW, Tuohy TM, Neklason DW, Burt RW. Hereditary and familial colon cancer. Gastroenterology 2010;138:2044-2058. https://doi.org/10.1053/j.gastro.2010.01.054
  5. Lee JY. Exploring the nexus between obesity, metabolic syndrome, and colorectal cancer. Kosin Med J 2024;39:18-25. https://doi.org/10.7180/kmj.24.107
  6. Center MM, Jemal A, Ward E. International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev 2009;18:1688-1694. https://doi.org/10.1158/1055-9965.EPI-09-0090
  7. Bardou M, Barkun AN, Martel M. Obesity and colorectal cancer. Gut 2013;62:933-947. https://doi.org/10.1136/gutjnl-2013-304701
  8. Sung H, Siegel RL, Torre LA, et al. Global patterns in excess body weight and the associated cancer burden. CA Cancer J Clin 2019;69:88-112. https://doi.org/10.3322/caac.21499
  9. Shin HY, Kang HT. Recent trends in the prevalence of underweight, overweight, and obesity in Korean adults: the Korean National Health and Nutrition Examination Survey from 1998 to 2014. J Epidemiol 2017;27:413-419. https://doi.org/10.1016/j.je.2016.08.014
  10. World Health Organization, Regional Office for the Western Pacific. The Asia-Pacific perspective: redefining obesity and its treatment. Health Communications Australia, 2000.
  11. Ning Y, Wang L, Giovannucci EL. A quantitative analysis of body mass index and colorectal cancer: findings from 56 observational studies. Obes Rev 2010;11:19-30. https://doi.org/10.1111/j.1467-789X.2009.00613.x
  12. Abar L, Vieira AR, Aune D, et al. Height and body fatness and colorectal cancer risk: an update of the WCRF-AICR systematic review of published prospective studies. Eur J Nutr 2018;57:1701-1720. https://doi.org/10.1007/s00394-017-1557-1
  13. Liu PH, Wu K, Ng K, et al. Association of obesity with risk of early-onset colorectal cancer among women. JAMA Oncol 2019;5:37-44. https://doi.org/10.1001/jamaoncol.2018.4280
  14. O'Sullivan DE, Sutherland RL, Town S, et al. Risk factors for early-onset colorectal cancer: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2022;20:1229-1240.e5. https://doi.org/10.1016/j.cgh.2021.01.037
  15. Kim BY, Kang SM, Kang JH, et al. 2020 Korean Society for the Study of Obesity guidelines for the management of obesity in Korea. J Obes Metab Syndr 2021;30:81-92. https://doi.org/10.7570/jomes21022
  16. Moore LL, Bradlee ML, Singer MR, et al. BMI and waist circumference as predictors of lifetime colon cancer risk in Framingham Study adults. Int J Obes Relat Metab Disord 2004;28:559-567. https://doi.org/10.1038/sj.ijo.0802606
  17. Gathirua-Mwangi WG, Monahan P, Song Y, et al. Changes in adult BMI and waist circumference are associated with increased risk of advanced colorectal neoplasia. Dig Dis Sci 2017;62:3177-3185. https://doi.org/10.1007/s10620-017-4778-5
  18. Ma Y, Yang Y, Wang F, et al. Obesity and risk of colorectal cancer: a systematic review of prospective studies. PLoS One 2013;8:e53916. https://doi.org/10.1371/journal.pone.0053916
  19. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004;4:579-591. https://doi.org/10.1038/nrc1408
  20. Lee H, Lee IS, Choue R. Obesity, inflammation and diet. Pediatr Gastroenterol Hepatol Nutr 2013;16:143-152. https://doi.org/10.5223/pghn.2013.16.3.143
  21. Rasic I, Rebic V, Rasic A, Aksamija G, Radovic S. The association of simultaneous increase in interleukin-6, C reactive protein, and matrix metalloproteinase-9 serum levels with increasing stages of colorectal cancer. J Oncol 2018;2018:2830503. https://doi.org/10.1155/2018/2830503
  22. Hidayat F, Labeda I, Sampetoding S, et al. Correlation of interleukin-6 and C-reactive protein levels in plasma with the stage and differentiation of colorectal cancer: a cross-sectional study in East Indonesia. Ann Med Surg (Lond) 2021;62:334-340. https://doi.org/10.1016/j.amsu.2021.01.013
  23. Wedell-Neergaard AS, Lang Lehrskov L, Christensen RH, et al. Exercise-induced changes in visceral adipose tissue mass are regulated by IL-6 signaling: a randomized controlled trial. Cell Metab 2019;29:844-855.e3. https://doi.org/10.1016/j.cmet.2018.12.007
  24. Chen YC, Chien CY, Hsu CC, et al. Obesity-associated leptin promotes chemoresistance in colorectal cancer through YAP-dependent AXL upregulation. Am J Cancer Res 2021;11:4220-4240.
  25. Kobayashi H, Gieniec KA, Lannagan TRM, et al. The origin and contribution of cancer-associated fibroblasts in colorectal carcinogenesis. Gastroenterology 2022;162:890-906. https://doi.org/10.1053/j.gastro.2021.11.037
  26. Li C, Quan J, Wei R, et al. Leptin overexpression as a poor prognostic factor for colorectal cancer. Biomed Res Int 2020;2020:7532514. https://doi.org/10.1155/2020/7532514
  27. Chavez-Talavera O, Tailleux A, Lefebvre P, Staels B. Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia, and nonalcoholic fatty liver disease. Gastroenterology 2017;152:1679-1694.e3. https://doi.org/10.1053/j.gastro.2017.01.055
  28. Lin H, An Y, Tang H, Wang Y. Alterations of bile acids and gut microbiota in obesity induced by high fat diet in rat model. J Agric Food Chem 2019;67:3624-3632. https://doi.org/10.1021/acs.jafc.9b00249
  29. Bayerdorffer E, Mannes GA, Richter WO, et al. Increased serum deoxycholic acid levels in men with colorectal adenomas. Gastroenterology 1993;104:145-151. https://doi.org/10.1016/0016-5085(93)90846-5
  30. Ochsenkuhn T, Bayerdorffer E, Meining A, et al. Colonic mucosal proliferation is related to serum deoxycholic acid levels. Cancer 1999;85:1664-1669. https://doi.org/10.1002/(SICI)1097-0142(19990415)85:8<1664::AID-CNCR4>3.0.CO;2-O
  31. Centuori SM, Gomes CJ, Trujillo J, et al. Deoxycholic acid mediates non-canonical EGFR-MAPK activation through the induction of calcium signaling in colon cancer cells. Biochim Biophys Acta 2016;1861:663-670. https://doi.org/10.1016/j.bbalip.2016.04.006
  32. Nguyen TT, Ung TT, Kim NH, Jung YD. Role of bile acids in colon carcinogenesis. World J Clin Cases 2018;6:577-588. https://doi.org/10.12998/wjcc.v6.i13.577
  33. Renehan AG, Frystyk J, Flyvbjerg A. Obesity and cancer risk: the role of the insulin-IGF axis. Trends Endocrinol Metab 2006;17:328-336. https://doi.org/10.1016/j.tem.2006.08.006
  34. Kasprzak A. Insulin-like growth factor 1 (IGF-1) signaling in glucose metabolism in colorectal cancer. Int J Mol Sci 2021;22:6434. https://doi.org/10.3390/ijms22126434
  35. Chen J, Katsifis A, Hu C, Huang XF. Insulin decreases therapeutic efficacy in colon cancer cell line HT29 via the activation of the PI3K/Akt pathway. Curr Drug Discov Technol 2011;8:119-125. https://doi.org/10.2174/157016311795563820
  36. Stefani C, Miricescu D, Stanescu-Spinu II, et al. Growth factors, PI3K/AKT/mTOR and MAPK signaling pathways in colorectal cancer pathogenesis: where are we now? Int J Mol Sci 2021;22:10260. https://doi.org/10.3390/ijms221910260
  37. Narayanankutty A. PI3K/ Akt/ mTOR pathway as a therapeutic target for colorectal cancer: a review of preclinical and clinical evidence. Curr Drug Targets 2019;20:1217-1226. https://doi.org/10.2174/1389450120666190618123846
  38. Higashimura Y, Naito Y, Takagi T, et al. Protective effect of agaro-oligosaccharides on gut dysbiosis and colon tumorigenesis in high-fat diet-fed mice. Am J Physiol Gastrointest Liver Physiol 2016;310:G367-G375. https://doi.org/10.1152/ajpgi.00324.2015
  39. Yang J, Wei H, Zhou Y, et al. High-fat diet promotes colorectal tumorigenesis through modulating gut microbiota and metabolites. Gastroenterology 2022;162:135-149.e2. https://doi.org/10.1053/j.gastro.2021.08.041
  40. Lee J, Meyerhardt JA, Giovannucci E, Jeon JY. Association between body mass index and prognosis of colorectal cancer: a meta-analysis of prospective cohort studies. PLoS One 2015;10:e0120706. https://doi.org/10.1371/journal.pone.0120706
  41. Jaspan V, Lin K, Popov V. The impact of anthropometric parameters on colorectal cancer prognosis: a systematic review and meta-analysis. Crit Rev Oncol Hematol 2021;159:103232. https://doi.org/10.1016/j.critrevonc.2021.103232
  42. Gruberg L, Weissman NJ, Waksman R, et al. The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox? J Am Coll Cardiol 2002;39:578-584. https://doi.org/10.1016/s0735-1097(01)01802-2
  43. Lennon H, Sperrin M, Badrick E, Renehan AG. The obesity paradox in cancer: a review. Curr Oncol Rep 2016;18:56. https://doi.org/10.1007/s11912-016-0539-4
  44. Jo HH, Kim N, Jang J, et al. Impact of body mass index on survival depending on sex in 14,688 patients with gastric cancer in a tertiary hospital in South Korea. Gut Liver 2023;17:243-258. https://doi.org/10.5009/gnl220104
  45. Li Y, Li C, Wu G, et al. The obesity paradox in patients with colorectal cancer: a systematic review and meta-analysis. Nutr Rev 2022;80:1755-1768. https://doi.org/10.1093/nutrit/nuac005
  46. Almasaudi AS, McSorley ST, Edwards CA, McMillan DC. The relationship between body mass index and short term postoperative outcomes in patients undergoing potentially curative surgery for colorectal cancer: a systematic review and meta-analysis. Crit Rev Oncol Hematol 2018;121:68-73. https://doi.org/10.1016/j.critrevonc.2017.12.004
  47. Fung A, Trabulsi N, Morris M, et al. Laparoscopic colorectal cancer resections in the obese: a systematic review. Surg Endosc 2017;31:2072-2088. https://doi.org/10.1007/s00464-016-5209-y
  48. Thompson HJ, Zhu Z, Jiang W. Dietary energy restriction in breast cancer prevention. J Mammary Gland Biol Neoplasia 2003;8:133-142. https://doi.org/10.1023/a:1025743607445
  49. Lauby-Secretan B, Scoccianti C, Loomis D, Grosse Y, Bianchini F, Straif K. Body fatness and cancer-viewpoint of the IARC working group. N Engl J Med 2016;375:794-798. https://doi.org/10.1056/NEJMsr1606602
  50. Christakoudi S, Pagoni P, Ferrari P, et al. Weight change in middle adulthood and risk of cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Int J Cancer 2021;148:1637-1651. https://doi.org/10.1002/ijc.33339
  51. Luo J, Hendryx M, Manson JE, et al. Intentional weight loss and obesity-related cancer risk. JNCI Cancer Spectr 2019;3:pkz054. https://doi.org/10.1093/jncics/pkz054
  52. Almazeedi S, El-Abd R, Al-Khamis A, Albatineh AN, Al-Sabah S. Role of bariatric surgery in reducing the risk of colorectal cancer: a meta-analysis. Br J Surg 2020;107:348-354. https://doi.org/10.1002/bjs.11494
  53. Taube M, Peltonen M, Sjoholm K, et al. Long-term incidence of colorectal cancer after bariatric surgery or usual care in the Swedish Obese Subjects study. PLoS One 2021;16:e0248550. https://doi.org/10.1371/journal.pone.0248550
  54. Chen H, Ye C, Wu C, et al. Berberine inhibits high fat diet-associated colorectal cancer through modulation of the gut microbiota-mediated lysophosphatidylcholine. Int J Biol Sci 2023;19:2097-2113. https://doi.org/10.7150/ijbs.81824